138 related articles for article (PubMed ID: 30430542)
1. Gastrointestinal involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective case series.
Gendreau S; Amiot A; Le Baleur Y; Charpy C; Wolkenstein P; Chosidow O; Mekontso Dessap A; Ingen-Housz-Oro S; de Prost N
Br J Dermatol; 2019 May; 180(5):1234-1235. PubMed ID: 30430542
[No Abstract] [Full Text] [Related]
2. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
[TBL] [Abstract][Full Text] [Related]
3. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
[TBL] [Abstract][Full Text] [Related]
4. Intestinal involvement in toxic epidermal necrolysis. A case report and review of literature.
Fava P; Astrua C; Cavaliere G; Brizio M; Savoia P; Quaglino P; Fierro MT
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1843-5. PubMed ID: 24754517
[No Abstract] [Full Text] [Related]
5. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
East-Innis AD; Thompson DS
West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
[TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
[TBL] [Abstract][Full Text] [Related]
7. Esophageal stricture secondary to drug-induced toxic epidermal necrolysis.
Herman TE; Kushner DC; Cleveland RH
Pediatr Radiol; 1984; 14(6):439-40. PubMed ID: 6504607
[TBL] [Abstract][Full Text] [Related]
8. Dark skin phototype is associated with more severe ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Thorel D; Delcampe A; Ingen-Housz-Oro S; Hajj C; Gabison E; Chosidow O; Wolkenstein P; Royer G; Ezzedine K; Muraine M; Gueudry J
Br J Dermatol; 2019 Jul; 181(1):212-213. PubMed ID: 30633324
[No Abstract] [Full Text] [Related]
9. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
[TBL] [Abstract][Full Text] [Related]
10. Esophageal stricture as a late complication of Stevens-Johnson syndrome.
Tan YM; Goh KL
Gastrointest Endosc; 1999 Oct; 50(4):566-8. PubMed ID: 10502184
[No Abstract] [Full Text] [Related]
11. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
12. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
[TBL] [Abstract][Full Text] [Related]
13. Toxic epidermal necrolysis co-existing with severe onset of ulcerative colitis--different condition or extraintestinal feature?--case report.
Aporowicz M; Czopnik P
Int J Colorectal Dis; 2016 Mar; 31(3):781-3. PubMed ID: 26105743
[No Abstract] [Full Text] [Related]
14. Esophageal stricture complicating Stevens-Johnson syndrome. A case report.
Stein MR; Thompson CK; Sawicki JE; Martel AJ
Am J Gastroenterol; 1974 Nov; 62(5):435-9. PubMed ID: 4440676
[No Abstract] [Full Text] [Related]
15. Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases.
Kara A; Devrim İ; Çağlar İ; Bayram N; Kundak S; Apa H; Altan EV
Turk J Pediatr; 2019; 61(4):538-543. PubMed ID: 31990471
[TBL] [Abstract][Full Text] [Related]
16. Benign oesophageal stricture--a sequel of Stevens Johnson syndrome.
Sathiyasekaran M; Shivbalan S
Indian J Pediatr; 2005 Aug; 72(8):711. PubMed ID: 16131782
[No Abstract] [Full Text] [Related]
17. COVID-19 infection increases the development of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective cohort analysis.
Curtis KK; Dillan MM; Sharma TR; Piktel J
J Am Acad Dermatol; 2024 Jun; 90(6):1300-1302. PubMed ID: 38423469
[No Abstract] [Full Text] [Related]
18. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
[TBL] [Abstract][Full Text] [Related]
19. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
20. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
